ABL Bio Inc. (KOSDAQ:298380)

South Korea · Delayed Price · Currency is KRW

74,500

+400 (0.54%)

Aug 8, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2017 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2017 - 2018
Bio-Protein Recombinant Medicines	65.55B	Log In	Log In	Log In	Log In	Upgrade
Bio-Protein Recombinant Medicines Growth	-2.61%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2017 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2017 - 2018
United States	63.55B	Log In	Log In	Log In	Log In	Upgrade
United States Growth	1.98%	Log In	Log In	Log In	Log In	Upgrade
South Korea	2.00B	Log In	Log In	Log In	Log In	Upgrade
South Korea Growth	-16.30%	Log In	Log In	Log In	Log In	Upgrade
China	-	Log In	Log In	Log In	Log In	Upgrade